Junshi Biosciences Announces FDA’s Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
The Register on MSN

Microsoft kills 9.9-rated ASP.NET Core bug – 'our highest ever' score

Flaw in Kestrel web server allowed request smuggling, impact depends on hosting setup and application code Microsoft has ...
The Frederick News-Post

City to seek development designation around downtown MARC station

Frederick plans to apply for a development designation around the downtown MARC station on East Street that could provide ...

MGX Launches No-Code AI App Builder to Automate Custom Application Development

Fresh off its recent, prestigious recognition as a top no-code AI builder, MGX (MetaGPT X) today announced the landmark ...

I've tested free vs. paid AI coding tools - here's which one I'd actually use

Some developers pay big for AI coding tools. Others stick with free. Here's how to know when to spend - and when to save.